Department of the Army June 27, 2017 – Federal Register Recent Federal Regulation Documents

In accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i), announcement is made of the intent to grant an exclusive, royalty- bearing, revocable license to U.S. Patent 7,956,086, issued June 7, 2011, entitled, ``Methods for the Formulation and Manufacture of Artesunic Acid for Injection'' to Amivas, LLC, having its principal place of business at 8403 Colesville Road, Suite 630, Silver Spring, Maryland 20910.